<DOC>
	<DOCNO>NCT00657384</DOCNO>
	<brief_summary>Blood loss report prognostic risk factor morbidity overall survival hepatic resection . The aim study prospective randomize compare efficacy administration tranexamic acid versus placebo reduce perioperative bleeding major hepatectomy ( &gt; 3 hepatic segment ) .</brief_summary>
	<brief_title>Tranexamic Acid Versus Placebo Reduce Perioperative Bleeding After Major Hepatectomy</brief_title>
	<detailed_description />
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Signature consent form Patients hepatic lesion need major hepatectomy ( â‰¥ 3 hepatic segment ) Absence signature consent form Patient cirrhosis Minor hepatectomy ( &lt; 3 hepatic segment ) Hepatectomy associate vascular resection Contraindication tranexamic acid : history arterial venous thrombosis , disseminate intravascular coagulation , severe renal insufficiency , history epilepsy , intrathecal intraventricular injection Pregnant lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Specify primary condition disease study Major Hepatectomy</keyword>
</DOC>